Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 554

1.

The Thrill of Discovery: A Personal Scientific Autobiography.

Robinson RG.

Am J Geriatr Psychiatry. 2017 Sep;25(9):1033-1039. doi: 10.1016/j.jagp.2017.05.004. Epub 2017 May 9. No abstract available.

PMID:
28595748
2.

Prevention of Poststroke Mortality Using Problem-Solving Therapy or Escitalopram.

Robinson RG, Jorge RE, Long J.

Am J Geriatr Psychiatry. 2017 May;25(5):512-519. doi: 10.1016/j.jagp.2016.10.001. Epub 2016 Oct 8.

PMID:
28029510
3.

Sertraline for Preventing Mood Disorders Following Traumatic Brain Injury: A Randomized Clinical Trial.

Jorge RE, Acion L, Burin DI, Robinson RG.

JAMA Psychiatry. 2016 Oct 1;73(10):1041-1047. doi: 10.1001/jamapsychiatry.2016.2189.

PMID:
27626622
4.

Synthesis and optimization of N-heterocyclic pyridinones as catechol-O-methyltransferase (COMT) inhibitors.

Zhao Z, Harrison ST, Schubert JW, Sanders JM, Polsky-Fisher S, Zhang NR, McLoughlin D, Gibson CR, Robinson RG, Sachs NA, Kandebo M, Yao L, Smith SM, Hutson PH, Wolkenberg SE, Barrow JC.

Bioorg Med Chem Lett. 2016 Jun 15;26(12):2952-2956. doi: 10.1016/j.bmcl.2016.03.095. Epub 2016 Apr 7.

PMID:
27133481
5.

A Randomized, Placebo-Controlled, Double-Blind Efficacy Study of Nefiracetam to Treat Poststroke Apathy.

Starkstein SE, Brockman S, Hatch KK, Bruce DG, Almeida OP, Davis WA, Robinson RG.

J Stroke Cerebrovasc Dis. 2016 May;25(5):1119-1127. doi: 10.1016/j.jstrokecerebrovasdis.2016.01.032. Epub 2016 Feb 22.

PMID:
26915605
6.

Post-Stroke Depression: A Review.

Robinson RG, Jorge RE.

Am J Psychiatry. 2016 Mar 1;173(3):221-31. doi: 10.1176/appi.ajp.2015.15030363. Epub 2015 Dec 18. Review.

PMID:
26684921
7.

Longitudinal Neuropsychiatric Predictors of Death in Alzheimer's Disease.

Spalletta G, Long JD, Robinson RG, Trequattrini A, Pizzoli S, Caltagirone C, Orfei MD.

J Alzheimers Dis. 2015;48(3):627-36. doi: 10.3233/JAD-150391.

PMID:
26402103
8.

A Cellular Assay for Inhibitors of the Fatty Acid Biosynthetic Pathway Using Scintillating Microplates.

Ung T, Mason JL, Robinson RG, Spais CM, Ator MA, Angeles TS.

Assay Drug Dev Technol. 2015 Jun;13(5):285-92. doi: 10.1089/adt.2015.644. Epub 2015 Jun 30.

PMID:
26125659
9.

Synthesis and Evaluation of Heterocyclic Catechol Mimics as Inhibitors of Catechol-O-methyltransferase (COMT).

Harrison ST, Poslusney MS, Mulhearn JJ, Zhao Z, Kett NR, Schubert JW, Melamed JY, Allison TJ, Patel SB, Sanders JM, Sharma S, Smith RF, Hall DL, Robinson RG, Sachs NA, Hutson PH, Wolkenberg SE, Barrow JC.

ACS Med Chem Lett. 2015 Jan 26;6(3):318-23. doi: 10.1021/ml500502d. eCollection 2015 Mar 12.

10.

Efficacy of a DVD-based smoking cessation intervention for African Americans.

Webb Hooper M, Baker EA, Robinson RG.

Nicotine Tob Res. 2014 Oct;16(10):1327-35. doi: 10.1093/ntr/ntu079. Epub 2014 May 16.

11.

The early course of affective and cognitive symptoms in de novo patients with Parkinson's disease.

Spalletta G, Robinson RG, Cravello L, Pontieri FE, Pierantozzi M, Stefani A, Long JD, Caltagirone C, Assogna F.

J Neurol. 2014 Jun;261(6):1126-32. doi: 10.1007/s00415-014-7327-6. Epub 2014 Apr 3.

PMID:
24695996
12.

Prevention of post-stroke generalized anxiety disorder, using escitalopram or problem-solving therapy.

Mikami K, Jorge RE, Moser DJ, Arndt S, Jang M, Solodkin A, Small SL, Fonzetti P, Hegel MT, Robinson RG.

J Neuropsychiatry Clin Neurosci. 2014 Fall;26(4):323-8. doi: 10.1176/appi.neuropsych.11020047.

PMID:
24457590
13.

Mortality in patients with traumatic brain injury.

Robinson RG.

JAMA Psychiatry. 2014 Mar;71(3):234-5. doi: 10.1001/jamapsychiatry.2013.4241. No abstract available.

PMID:
24430767
14.

Results of the citalopram to enhance cognition in Huntington disease trial.

Beglinger LJ, Adams WH, Langbehn D, Fiedorowicz JG, Jorge R, Biglan K, Caviness J, Olson B, Robinson RG, Kieburtz K, Paulsen JS.

Mov Disord. 2014 Mar;29(3):401-5. doi: 10.1002/mds.25750. Epub 2013 Dec 27.

15.

Neuropsychiatric symptoms and interleukin-6 serum levels in acute stroke.

Spalletta G, Cravello L, Imperiale F, Salani F, Bossù P, Picchetto L, Cao M, Rasura M, Pazzelli F, Orzi F, Caltagirone C, Robinson RG, Cacciari C.

J Neuropsychiatry Clin Neurosci. 2013 Fall;25(4):255-63. doi: 10.1176/appi.neuropsych.12120399.

PMID:
24247852
16.

Prevention of poststroke apathy using escitalopram or problem-solving therapy.

Mikami K, Jorge RE, Moser DJ, Arndt S, Jang M, Solodkin A, Small SL, Fonzetti P, Hegel MT, Robinson RG.

Am J Geriatr Psychiatry. 2013 Sep;21(9):855-62. doi: 10.1016/j.jagp.2012.07.003. Epub 2013 Feb 6.

PMID:
23930743
17.

Evolving research in the geriatric neuropsychiatry of stroke.

Robinson RG.

Am J Geriatr Psychiatry. 2013 Sep;21(9):817-20. doi: 10.1016/j.jagp.2013.06.006. No abstract available.

PMID:
23930742
18.

Incident apathy during the first year after stroke and its effect on physical and cognitive recovery.

Mikami K, Jorge RE, Moser DJ, Jang M, Robinson RG.

Am J Geriatr Psychiatry. 2013 Sep;21(9):848-54. doi: 10.1016/j.jagp.2013.03.012. Epub 2013 Jul 3.

PMID:
23831176
19.

Culturally specific versus standard group cognitive behavioral therapy for smoking cessation among African Americans: an RCT protocol.

Hooper MW, Larry R, Okuyemi K, Resnicow K, Dietz NA, Robinson RG, Antoni MH.

BMC Psychol. 2013 Aug 21;1(1):15. doi: 10.1186/2050-7283-1-15. eCollection 2013.

20.

Characterization of non-nitrocatechol pan and isoform specific catechol-O-methyltransferase inhibitors and substrates.

Robinson RG, Smith SM, Wolkenberg SE, Kandebo M, Yao L, Gibson CR, Harrison ST, Polsky-Fisher S, Barrow JC, Manley PJ, Mulhearn JJ, Nanda KK, Schubert JW, Trotter BW, Zhao Z, Sanders JM, Smith RF, McLoughlin D, Sharma S, Hall DL, Walker TL, Kershner JL, Bhandari N, Hutson PH, Sachs NA.

ACS Chem Neurosci. 2012 Feb 15;3(2):129-40. doi: 10.1021/cn200109w. Epub 2011 Nov 14.

21.

Improving recovery after stroke: a role for antidepressant medications?

Adams HP Jr, Robinson RG.

Stroke. 2012 Oct;43(10):2829-32. Epub 2012 Aug 2. No abstract available.

PMID:
22858725
22.

Stroke.

Robinson RG, Spalletta G.

Handb Clin Neurol. 2012;106:491-506. doi: 10.1016/B978-0-444-52002-9.00029-2. Review. No abstract available.

PMID:
22608640
23.

Treatment of late-life depression: a role of non-invasive brain stimulation techniques.

Jorge RE, Robinson RG.

Int Rev Psychiatry. 2011 Oct;23(5):437-44. doi: 10.3109/09540261.2011.633501. Review.

24.

Increased frequency of first-episode poststroke depression after discontinuation of escitalopram.

Mikami K, Jorge RE, Moser DJ, Arndt S, Jang M, Solodkin A, Small SL, Fonzetti P, Hegel MT, Robinson RG.

Stroke. 2011 Nov;42(11):3281-3. doi: 10.1161/STROKEAHA.111.626507. Epub 2011 Aug 25.

25.

Diagnostic criteria for depression in Parkinson's disease: a study of symptom patterns using latent class analysis.

Starkstein S, Dragovic M, Jorge R, Brockman S, Merello M, Robinson RG, Bruce D, Wilson M.

Mov Disord. 2011 Oct;26(12):2239-45. doi: 10.1002/mds.23836. Epub 2011 Jul 7.

PMID:
21739470
26.

Diagnostic criteria for depression in Alzheimer disease: a study of symptom patterns using latent class analysis.

Starkstein SE, Dragovic M, Jorge R, Brockman S, Robinson RG.

Am J Geriatr Psychiatry. 2011 Jun;19(6):551-8. doi: 10.1097/JGP.0b013e3181ec897f.

PMID:
21606898
27.

Effect of antidepressants on the course of disability following stroke.

Mikami K, Jorge RE, Adams HP Jr, Davis PH, Leira EC, Jang M, Robinson RG.

Am J Geriatr Psychiatry. 2011 Dec;19(12):1007-15. doi: 10.1097/JGP.0b013e31821181b0.

28.

Selective serotonin-reuptake inhibitors and recovery after stroke.

Robinson RG, Adams HP.

Lancet Neurol. 2011 Feb;10(2):110-1. doi: 10.1016/S1474-4422(10)70326-4. Epub 2011 Jan 7. No abstract available.

PMID:
21216671
29.

Limbic metabolic abnormalities in remote traumatic brain injury and correlation with psychiatric morbidity and social functioning.

Capizzano AA, Jorge RE, Robinson RG.

J Neuropsychiatry Clin Neurosci. 2010 Fall;22(4):370-7. doi: 10.1176/appi.neuropsych.22.4.370.

30.

Altered neural activity and emotions following right middle cerebral artery stroke.

Paradiso S, Anderson BM, Boles Ponto LL, Tranel D, Robinson RG.

J Stroke Cerebrovasc Dis. 2011 Mar-Apr;20(2):94-104. doi: 10.1016/j.jstrokecerebrovasdis.2009.11.005. Epub 2010 Jul 24.

31.

How should depression be diagnosed in patients with stroke?

Spalletta G, Robinson RG.

Acta Psychiatr Scand. 2010 Jun;121(6):401-3. doi: 10.1111/j.1600-0447.2010.01569.x. No abstract available.

PMID:
20550629
32.

The frequency, clinical correlates, and mechanism of anosognosia after stroke.

Starkstein SE, Jorge RE, Robinson RG.

Can J Psychiatry. 2010 Jun;55(6):355-61. Review.

PMID:
20540830
33.

Apathy following stroke.

Jorge RE, Starkstein SE, Robinson RG.

Can J Psychiatry. 2010 Jun;55(6):350-4. Review.

PMID:
20540829
34.

Poststroke depression: a review.

Robinson RG, Spalletta G.

Can J Psychiatry. 2010 Jun;55(6):341-9. Review.

35.

Neuropsychiatric disorders following stroke.

Robinson RG.

Can J Psychiatry. 2010 Jun;55(6):339-40. No abstract available.

PMID:
20540827
36.

Subgenual cingulate theta activity predicts treatment response of repetitive transcranial magnetic stimulation in participants with vascular depression.

Narushima K, McCormick LM, Yamada T, Thatcher RW, Robinson RG.

J Neuropsychiatry Clin Neurosci. 2010 Winter;22(1):75-84. doi: 10.1176/appi.neuropsych.22.1.75.

37.

Escitalopram and enhancement of cognitive recovery following stroke.

Jorge RE, Acion L, Moser D, Adams HP Jr, Robinson RG.

Arch Gen Psychiatry. 2010 Feb;67(2):187-96. doi: 10.1001/archgenpsychiatry.2009.185.

38.

Frequency and correlates of involuntary emotional expression disorder in Parkinson's disease.

Petracca GM, Jorge RE, Ación L, Weintraub D, Robinson RG.

J Neuropsychiatry Clin Neurosci. 2009 Fall;21(4):406-12. doi: 10.1176/appi.neuropsych.21.4.406.

PMID:
19996249
39.

Citalopram for continuation therapy after repetitive transcranial magnetic stimulation in vascular depression.

Robinson RG, Tenev V, Jorge RE.

Am J Geriatr Psychiatry. 2009 Aug;17(8):682-7. doi: 10.1097/JGP.0b013e3181a88423.

40.

Double-blind treatment of apathy in patients with poststroke depression using nefiracetam.

Robinson RG, Jorge RE, Clarence-Smith K, Starkstein S.

J Neuropsychiatry Clin Neurosci. 2009 Spring;21(2):144-51. doi: 10.1176/appi.neuropsych.21.2.144.

PMID:
19622685
41.

Top cited papers in international psychogeriatrics: 5. A controlled study of repetitive transcranial magnetic stimulation as a treatment of depression in the elderly.

Jorge RE, Robinson RG, O'Brien J.

Int Psychogeriatr. 2009 Oct;21(5):855-60. doi: 10.1017/S1041610209990603. Epub 2009 Jul 10. No abstract available.

PMID:
19589195
42.

Disease outcome, alexithymia and depression are differently associated with serum IL-18 levels in acute stroke.

Bossù P, Salani F, Cacciari C, Picchetto L, Cao M, Bizzoni F, Rasura M, Caltagirone C, Robinson RG, Orzi F, Spalletta G.

Curr Neurovasc Res. 2009 Aug;6(3):163-70. Epub 2009 Aug 1.

PMID:
19534720
43.

Prevention of first-episode depression: progress and potential.

Robinson RG, Jorge RE.

Br J Psychiatry. 2009 Apr;194(4):296-7. doi: 10.1192/bjp.bp.108.059873.

PMID:
19336777
44.

Is family history of depression a risk factor for poststroke depression? Meta-analysis.

Tenev VT, Robinson RG, Jorge RE.

Am J Geriatr Psychiatry. 2009 Apr;17(4):276-80. doi: 10.1097/JGP.0b013e3181953b6e.

45.

Incomplete financial disclosure in a study of escitalopram and problem-solving therapy for prevention of poststroke depression.

Robinson RG, Arndt S.

JAMA. 2009 Mar 11;301(10):1023-4. doi: 10.1001/jama.2009.256. No abstract available.

PMID:
19278945
46.

Allosteric inhibitors of Akt1 and Akt2: discovery of [1,2,4]triazolo[3,4-f][1,6]naphthyridines with potent and balanced activity.

Li Y, Liang J, Siu T, Hu E, Rossi MA, Barnett SF, Defeo-Jones D, Jones RE, Robinson RG, Leander K, Huber HE, Mittal S, Cosford N, Prasit P.

Bioorg Med Chem Lett. 2009 Feb 1;19(3):834-6. doi: 10.1016/j.bmcl.2008.12.017. Epub 2008 Dec 7.

PMID:
19097777
47.

Decreased heart rate variability is associated with poststroke depression.

Robinson RG, Spalletta G, Jorge RE, Bassi A, Colivicchi F, Ripa A, Caltagirone C.

Am J Geriatr Psychiatry. 2008 Nov;16(11):867-73. doi: 10.1097/JGP.0b013e318180057d.

48.

Aging and alexithymia: association with reduced right rostral cingulate volume.

Paradiso S, Vaidya JG, McCormick LM, Jones A, Robinson RG.

Am J Geriatr Psychiatry. 2008 Sep;16(9):760-9. doi: 10.1097/JGP.0b013e31817e73b0. Epub 2008 Aug 12.

49.

The design and synthesis of potent and cell-active allosteric dual Akt 1 and 2 inhibitors devoid of hERG activity.

Siu T, Li Y, Nagasawa J, Liang J, Tehrani L, Chua P, Jones RE, Defeo-Jones D, Barnett SF, Robinson RG.

Bioorg Med Chem Lett. 2008 Jul 15;18(14):4191-4. doi: 10.1016/j.bmcl.2008.05.084. Epub 2008 May 24.

PMID:
18550373
50.

Discovery of potent and cell-active allosteric dual Akt 1 and 2 inhibitors.

Siu T, Liang J, Arruda J, Li Y, Jones RE, Defeo-Jones D, Barnett SF, Robinson RG.

Bioorg Med Chem Lett. 2008 Jul 15;18(14):4186-90. doi: 10.1016/j.bmcl.2008.05.085. Epub 2008 May 24.

PMID:
18539456

Supplemental Content

Loading ...
Support Center